首页> 外国专利> Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis

Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis

机译:与miR-21和miR-29a,外泌体抑制和癌症转移有关的方法和成分

摘要

The present invention provides materials and methods related to the discovery that tumor secreted miR-21 and miR-29a can function by binding as ligands to receptors of the Tolllike receptor family, murine TLR7 and human TLR8, in immune cells, triggering a TLR-mediated prometastatic inflammatory response, which leads to tumor growth and metastasis. Thus, by acting as paracrine agonists of TLRs, secreted miRNAs are key regulators of the tumor microenvironment. This mechanism of action of miRNAs is important in the tumor-immune system communication, in tumor growth and spread, and in cancer treatment.
机译:本发明提供与以下发现有关的材料和方法:发现肿瘤分泌的miR-21和miR-29a可以通过与免疫细胞中Tolllike受体家族,鼠TLR7和人TLR8的受体的配体结合而起作用,从而触发TLR介导的转移性炎症反应,导致肿瘤生长和转移。因此,通过充当TLR的旁分泌激动剂,分泌的miRNA是肿瘤微环境的关键调节因子。 miRNA的这种作用机制在肿瘤与免疫系统的沟通,肿瘤的生长和扩散以及癌症治疗中都很重要。

著录项

  • 公开/公告号AU2012352265B2

    专利类型

  • 公开/公告日2017-02-16

    原文格式PDF

  • 申请/专利权人 OHIO STATE INNOVATION FOUNDATION;

    申请/专利号AU20120352265

  • 发明设计人 CROCE CARLO M.;FABBRI MULLER;

    申请日2012-12-13

  • 分类号A61K48;A61P35;C07H21/02;C12N5;

  • 国家 AU

  • 入库时间 2022-08-21 13:33:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号